Detalhe da pesquisa
1.
Diminishing Immune Responses against Variants of Concern in Dialysis Patients 4 Months after SARS-CoV-2 mRNA Vaccination.
Emerg Infect Dis
; 28(4): 743-750, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35203113
2.
Humoral immune response following prime and boost BNT162b2 vaccination in people living with HIV on antiretroviral therapy.
HIV Med
; 23(5): 558-563, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34725907
3.
The SARS-CoV-2 Delta-Omicron Recombinant Lineage (XD) Exhibits Immune-Escape Properties Similar to the Omicron (BA.1) Variant.
Int J Mol Sci
; 23(22)2022 Nov 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-36430535
4.
Humoral and Cellular Immune Responses Against Severe Acute Respiratory Syndrome Coronavirus 2 Variants and Human Coronaviruses After Single BNT162b2 Vaccination.
Clin Infect Dis
; 73(11): 2000-2008, 2021 12 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34134134
5.
Systems biology analysis reveals distinct molecular signatures associated with immune responsiveness to the BNT162b COVID-19 vaccine.
EBioMedicine
; 99: 104947, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38160529
6.
Longitudinal cellular and humoral immune responses after triple BNT162b2 and fourth full-dose mRNA-1273 vaccination in haemodialysis patients.
Front Immunol
; 13: 1004045, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36275672
7.
BNT162b2-boosted immune responses six months after heterologous or homologous ChAdOx1nCoV-19/BNT162b2 vaccination against COVID-19.
Nat Commun
; 13(1): 4872, 2022 08 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-35982040
8.
Cellular and humoral immunogenicity of a SARS-CoV-2 mRNA vaccine in patients on haemodialysis.
EBioMedicine
; 70: 103524, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-34391096
9.
Neutralisation sensitivity of the SARS-CoV-2 XBB.1 lineage.
Lancet Infect Dis
; 23(2): 147-148, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36620969